Company intelligence / Profile preview

AmnioChor

Ownership: Private
Employees: ~10
Development stage: Phase 2

Overview

AmnioChor has developed proprietary methods to retrieve, process, and cryopreserve the amniotic membrane of the placenta at birth. Their patented technologies enable storage of perinatal mesenchymal/epithelial stem cells with potential applications in regenerative medicine. The company’s OmniBank offers both personal/family banking as well as community donation models. They have developed several devices/kits to facilitate safe collection and preservation but have not yet reported clinical trial outcomes or commercialized therapeutic products.

Therapeutic areas: OtherOphthalmologyNeurology
Modalities: Perinatal stem cells (Mesenchymal and Epithelial stem cells from amniotic membrane)Cryopreserved placental tissueExtracellular vesicles
Industry: Biotech

Drug pipeline

2 assets

Brilacidin

Phase 2

Indications: COVID-19, Oral mucositis, Inflammatory bowel disease, Ulcerative proctitis, Ulcerative proctosigmoiditis, Acute bacterial skin and skin structure infection

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on AmnioChor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AmnioChor.

Explore the full profile